Speaker Details

William Damsky, PhD, MD, FAAD

William Damsky, PhD, MD, FAAD

SESSIONS

S008 JAK Inhibitors: A New Frontier in Dermatology
Mar 7, 2025 • 9:00 AM - 12:00 PM • Valencia Ballroom D
S029 What's New in Dermatopathology
Mar 8, 2025 • 9:00 AM - 12:00 PM • W311A
F073 Granulomatous Disorders of the Adult Skin
Mar 9, 2025 • 3:30 PM - 5:30 PM • Valencia Ballroom A

DISCLOSURES

AbbVie – Investigator(Fees); Advanced Cell Diagnostics, Inc. – Investigator(Equipment); Boehringer Ingelheim – Consultant (1099 relationship)(Fees); Bristol – Investigator(Grants/Research Funding); Bristol-Myers Squibb – Investigator(Grants/Research Funding); CSL Behring – Consultant (1099 relationship)(Fees); Eli Lilly and Company – Consultant(Fees); Epiarx Diagnostics – Consultant (1099 relationship)(Fees); Fresenius Kabi – Consultant (1099 relationship)(Fees); Incite – Investigator(Grants/Research Funding); Incyte Corporation – Consultant(Fees), Investigator(Grants/Research Funding); MilliporeSigma – Other(Patent royalties or other compensation for Intellectual Property Rights); Pfizer Inc. – Consultant(Fees), Investigator(Grants/Research Funding); Priovant Therapeutics – Consultant (1099 relationship)(Fees); Sanofi – Consultant (1099 relationship)(Fees); TWi Biote – Consultant (1099 relationship)(Fees); TWi Biotechnology, Inc. – Consultant(Fees), Consultant (1099 relationship)(Fees), Investigator(Fees);